Specialty Care

Ekawat, Hemophilia, Thailand

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, rare blood disorders, neurology, immunology, and oncology. It helps people with debilitating and complex conditions that are often difficult to diagnose and treat, and is dedicated to discovering and advancing new therapies, providing hope to patients and their families worldwide.

Sanofi Genzyme’s ambition is to be the industry leader in specialty care. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities.

Focus areas

Rare Diseases



Rare Blood Disorders


Our Responsibility

Sanofi Genzyme supports access to treatment through humanitarian programs to help ensure that appropriate treatment reaches all those who need it.


Sanofi has a strong pipeline with a significant portion of its R&D spending concentrated on specialty care.

Our Stories

Inspired by Rare Disease Patients Around the World

The Impact of COVID-19 on Cancer

Inside Sanofi’s Hemophilia Research


The Type 2 Inflammation Connection

Adjusting to Life with Multiple Myeloma: Bernard’s Story

Follow Sanofi Genzyme

Sanofi on Facebook    Sanofi on LinkedIn    Sanofi on Twitter